No Data
No Data
Evaluating Roivant Sciences: Insights From 6 Financial Analysts
Roivant Sciences (NASDAQ:ROIV) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.The table below provides a concise overview o
Cantor Fitzgerald Reiterates Overweight on Roivant Sciences
Cantor Fitzgerald analyst Louise Chen reiterates Roivant Sciences (NASDAQ:ROIV) with a Overweight.
Roivant Sciences' (NASDAQ:ROIV) Performance Raises Some Questions
Even though Roivant Sciences Ltd. (NASDAQ:ROIV) posted strong earnings recently, the stock hasn't reacted in a large way. We decided to have a deeper look, and we believe that investors might be worr
Buy Rating Justified by Roivant Sciences' Growth Prospects and Strategic Pipeline Expansion
Piper Sandler Keeps Their Buy Rating on Roivant Sciences (ROIV)
HC Wainwright & Co. : The Roivant Sciences (ROIV.US) rating was reaffirmed, adjusted from buy to buy rating, and the target price was adjusted from $18.00 to $18.00.
HC Wainwright & Co. : The Roivant Sciences (ROIV.US) rating was reaffirmed, adjusted from buy to buy rating, and the target price was adjusted from $18.00 to $18.00.